𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease

✍ Scribed by T. Sunderland; P. N. Tariot; R. M. Cohen; P. A. Newhouse; A. M. Mellow; E. A. Mueller; D. L. Murphy

Publisher
Springer
Year
1987
Tongue
English
Weight
478 KB
Volume
91
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A dose-ranging study of selegiline in pa
A dose-ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity
✍ Nathalie Andreu; Christine Damase-Michel; Jean-Michel Senard; Olivier Rascol; Pr πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract A dose‐ranging study of selegiline was performed in patients with Parkinson's disease to determine the minimal dosage of the drug able to inhibit β‰₯95% of platelet monoamine oxidase (MAO) activity. Different doses of selegiline (5 or 10 mg daily, 10 or 20 mg weekly) were studied in four

The effects of music therapy on reducing
The effects of music therapy on reducing agitation in patients with Alzheimer's disease, a pre-post study
✍ Maryam Zare; Azizeh Afkham Ebrahimi; Behrooz Birashk πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 3 views

A Memory Clinic model set up to diagnose and treat Alzheimer's Disease early in the course of the illness delayed time to institutionalisation by a median of 9 months compared to controls. Treatment included pre and post diagnostic counselling, and psychosocial interventions.